New inflammation inhibitor discovered

dna
Credit: CC0 Public Domain

A multidisciplinary team of researchers led from Karolinska Institutet in Sweden have developed an anti-inflammatory drug molecule with a new mechanism of action. By inhibiting a certain protein, the researchers were able to reduce the signals that trigger an inflammation. The study is published in Science and was done in collaboration with the University of Texas Medical Branch, Uppsala University and Stockholm University.

"We've developed a new drug molecule that inhibits ," says Professor Thomas Helleday at the Department of Oncology-Pathology, Karolinska Institutet, Sweden, who co-led the study with Dr. Torkild Visnes and Dr. Armando Cázares-Körner. "It acts on a protein that we believe is a general mechanism for how inflammation arises in cells."

The is the result of many years of research by Thomas Helleday's group on how DNA is repaired by the body. One of the objectives has been to fight cancer by targeting damage to the tumour cells' DNA. Several breakthroughs have already been reported, which have led, amongst other things, to a new treatment for congenital breast and using so-called PARP inhibitors, which has been available for some years.

It was when developing a new molecule for inhibiting the enzyme that repairs oxygen damage to DNA that the found, to their surprise, that it also dampened inflammation. It turned out that the enzyme OGG1, apart from repairing DNA, also triggers inflammation.

The inhibitor blocks the release of inflammatory proteins, such as TNF alpha. In trials on mice with acute pulmonary disease, the researchers succeeded in dampening the inflammation.

"This discovery could give rise to a new treatment for a very serious condition," says Professor Helleday. "We'll now be developing our OGG1 inhibitor and examining whether it can lead to new treatments for inflammatory diseases in order to cure or relieve diseases such as sepsis, COPD and severe asthma."


Explore further

New drug candidate makes cancer cells more sensitive to radiotherapy

More information: "Small-molecule inhibitor of OGG1 suppresses proinflammatory gene expression and inflammation" Science (2018). science.sciencemag.org/cgi/doi … 1126/science.aar8048
Journal information: Science

Citation: New inflammation inhibitor discovered (2018, November 16) retrieved 23 May 2019 from https://medicalxpress.com/news/2018-11-inflammation-inhibitor.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
540 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more